What are the changes in diagnosis of other specified bipolar and related disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) 10 and 11?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evolution of "Other Specified Bipolar and Related Disorder" Across DSM and ICD Classifications

Direct Answer to Diagnostic Changes

The "Other Specified Bipolar and Related Disorder" category represents a fundamental shift from the vague "Bipolar Disorder Not Otherwise Specified (NOS)" categories in DSM-III and DSM-IV to more operationally defined subthreshold bipolar syndromes in DSM-5 and DSM-5-TR, while ICD-11 has moved toward dimensional symptom assessment rather than expanding categorical subthreshold diagnoses. 1, 2

DSM Evolution: From NOS to Specified Categories

DSM-III and DSM-IV Era

  • Both DSM-III and DSM-IV relied heavily on the "Bipolar Disorder Not Otherwise Specified (NOS)" category, which was criticized as excessively vague and led to a large proportion of treated patients being allocated to this poorly defined group 1
  • This approach resulted in systematic underdiagnosis of bipolar spectrum conditions, as clinicians lacked operational criteria for subthreshold presentations 1

DSM-5 and DSM-5-TR Changes

  • DSM-5 replaced the NOS category with "Other Specified Bipolar and Related Disorder," which now requires clinicians to specify the reason the presentation does not meet full criteria (e.g., "short-duration hypomanic episodes and major depressive episodes") 1
  • Several new subthreshold groups of bipolar disorders are now operationally defined rather than lumped into a single NOS category 1
  • A critical restriction was added: entry criterion A now requires not only elated or irritable mood but also increased energy/activity for diagnosing hypomania or mania 1, 2
  • This energy/activity requirement paradoxically shifted some patients who would have met DSM-IV criteria for Bipolar I or II into the "Other Specified" category, potentially delaying diagnosis and treatment 1, 3
  • Studies demonstrate a 30-50% decrease in point prevalence of bipolar disorder diagnoses with DSM-5 compared to DSM-IV, though lifetime prevalence decreased only 6% 3

ICD Evolution: From Categorical to Dimensional

ICD-10 Approach

  • ICD-10 maintained a purely categorical approach to bipolar disorders without dimensional expansions 4
  • The classification lacked operational definitions for subthreshold bipolar presentations 4

ICD-11 Revolutionary Changes

  • ICD-11 fundamentally restructured the entire mental disorders chapter, grouping bipolar disorders with dimensional symptom specifiers across six domains: positive symptoms, negative symptoms, depressive symptoms, manic symptoms, psychomotor symptoms, and cognitive symptoms 4, 5, 6
  • Rather than expanding "Other Specified" categories, ICD-11 emphasizes rating symptom severity on a 4-point scale ranging from "not present" to "present and severe" for each domain 4
  • ICD-11 added dimensional qualifiers for depressive episodes including melancholic features, anxiety symptoms, panic attacks, and seasonal pattern 4
  • Severity ratings (mild, moderate, severe) and remission status (partial or full) provide nuanced characterization without creating multiple categorical subdivisions 4
  • Like DSM-5, ICD-11 requires increased activity or energy in addition to mood elevation or irritability for diagnosing hypomania 7, 2

Key Harmonization Between DSM-5 and ICD-11

  • Both systems now require the additional criterion of increased activity/energy for hypomania and mania diagnosis, representing the most significant point of convergence 2
  • Both eliminated traditional subtypes in favor of dimensional severity specifiers 5, 6
  • Both moved away from purely categorical classification toward incorporating dimensional assessment, though ICD-11 went further in this direction 4, 5

Clinical Implications and Pitfalls

Diagnostic Delay Risk

  • The stricter energy/activity requirement in both DSM-5 and ICD-11 likely results in diagnostic delay and delayed early intervention for bipolar disorder 3
  • Patients with prominent mood symptoms but less obvious energy changes may be misclassified into "Other Specified" categories or depressive disorders 1, 3

Field Study Performance

  • ICD-11 demonstrated superior clinical utility with 82.5% to 83.9% of clinicians rating it as quite or extremely easy to use, accurate, clear, and understandable 5, 7
  • Field studies showed small but measurable improvements in diagnostic accuracy with ICD-11 compared to ICD-10, though advantages were largely limited to new diagnostic categories 5
  • When excluding new categories, differences in diagnostic accuracy between ICD-11 and ICD-10 were not significant 5

Practical Assessment Recommendations

  • Use structured diagnostic interviews rather than unstructured clinical assessment to reduce diagnostic bias when evaluating subthreshold presentations 5
  • Create detailed life charts documenting longitudinal symptom patterns, as the "Other Specified" diagnosis frequently evolves over time and may require reclassification 5
  • Gather collateral information from family members, as patient insight may be limited regarding energy/activity changes during mood episodes 5
  • Document dimensional symptom severity across multiple domains at each assessment using ICD-11 framework, providing flexibility for treatment planning 5

Remaining Limitations

  • Both DSM-5-TR and ICD-11 remain fundamentally categorical at their core, classifying based on observable symptoms rather than underlying pathophysiology 5
  • Neither system has biological validation, resulting in biologically heterogeneous groups within the same diagnostic category 6
  • Changes from previous versions were relatively modest despite efforts toward dimensionality 5

References

Research

Bipolar disorders in DSM-5: strengths, problems and perspectives.

International journal of bipolar disorders, 2013

Research

Bipolar disorders in the new DSM-5 and ICD-11 classifications.

Revista de psiquiatria y salud mental, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Schizoaffective Disorder Diagnostic Criteria Evolution

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evolution of Schizophreniform Disorder Diagnostic Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Criteria for Bipolar II Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing substance/medication-induced bipolar and related disorder?
What are the changes in diagnosis of unspecified bipolar and related disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) 10 and 11?
What are the changes in diagnosis of bipolar and related disorders due to another medical condition across Diagnostic and Statistical Manual of Mental Disorders (DSM) 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) 10 and 11?
What are the changes in the diagnosis of Bipolar I disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) (Diagnostic and Statistical Manual of Mental Disorders) versions 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) (International Classification of Diseases) versions 10 and 11?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing bipolar and related disorders due to another medical condition in an adult patient with a complex medical history?
What are the management options for a patient with localized, early-stage vulvar cancer?
What is the difference between a comprehensive metabolic panel (CMP) and a renal panel in evaluating a patient's health, particularly for those with a history of kidney disease, diabetes, or hypertension?
What are the causes and risk factors of Helicobacter Pylori (H. Pylori) infection in adults?
What is the recommended dose of Eliquis (apixaban) for a patient with atrial fibrillation (AFib) and normal renal function?
What is the relationship between alcohol use and eating disorder purging in patients with bulimia nervosa?
What is the recommended management approach for a patient presenting with sciatica pain in the outpatient department (OPD) setting?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.